With its 92-year-old football stadium starting to crumble, the University of Washington began contemplating a renovation half a dozen years ago. One financing idea -- getting $150 million from Seattle-area taxpayers -- ran afoul of state Representative Ross Hunter. The state was reducing college funding, and tuition was surging.
A combination of two Vertex Pharmaceuticals Inc. drugs improved lung function in patients with the most common form of cystic fibrosis, holding out the promise of a new treatment for the genetic illness. The company’s shares rose to their highest price in almost 14 years.
Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a growing group of women, following a U.S. Supreme Court ruling that ended Myriad Genetics Inc.’s monopoly over DNA that vastly raises odds for the disease.